The Cannula Quest: Journey into Market Evolution
The cannula market involves medical tubing that serves as a conduit for inserting and draining body fluids or providing access to surgical instruments. Cannulas are commonly used during minimally invasive procedures like laparoscopy for facilitating easy passage of instruments through small incisions. The increasing preference for minimally invasive surgeries over conventional open surgeries is a key factor driving demand for cannulas globally. Minimally invasive procedures minimize hospital stay, recovery time, and risk of postoperative complications. The Global Cannula Market is estimated to be valued at US$ 180.4 Mn in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030. Key Takeaways Key players operating in the cannula market are Smith & Nephew, Maquel Holding B.V. & Co. KG., Sorin Group, Edward Lifescience Corporation, Medtronic plc, Terumo Corporation, Boston Scientific Corporation, Teleflex Incorporated, Conmed Corporation, Dolphin Surgicals, Micromed International, Goodhealth Inc., and Biotek (Chetan Meditech Pvt. Ltd.). These players dominate the global cannula market with their wide product portfolio and strong geographical presence across major markets. The rising acceptance of minimally invasive procedures presents lucrative opportunities for cannula manufacturers globally. Growing geriatric population suffering from chronic conditions will necessitate more surgical procedures, boosting cannula demand. Cannula suppliers are enhancing their R&D capabilities and production lines to cater to rising complex surgeries worldwide. Geographic expansion into emerging regions is a key focus for major cannula companies. Significant unmet needs in Asia Pacific and Latin America offer scope for cannula providers to augment their shares in these markets. Partnerships with local medical product distributors facilitate smooth supply and after-sales services. Market drivers: 1) Increasing preference for minimally invasive surgeries - Growth in laparoscopic, arthroscopic and other MIS procedures worldwide is a major factor necessitating more cannulas. According to industry estimates, MIS procedures are growing at 10-15% annually. 2) Rising geriatric population- Growing prevalence of chronic diseases among the elderly drive surgical volumes and subsequent demand for cannulas used in these surgeries. As per UN data, over 16% of global population will be aged 65+ by 2050. Market restrain: 1) Higher costs compared to conventional devices: Cannulas have a relatively higher acquisition cost than traditional surgical tools, limiting their adoption in price sensitive areas. This can restrain market revenues especially in developing nations. 2) Training and sterilization challenges: Effective use of cannulas requires specialized training of surgeons and operating staff. Their reuse after sterilization also poses contamination risks if not done properly. This adds to set up and maintenance costs for healthcare facilities.
Segment Analysis The global cannula market can be segmented based on product type, application, end-use, and region. Based on product type, the needles segment dominates the market as it is widely used for diagnostic and therapeutic procedures. Based on application, the cardiovascular surgery sub-segment dominates as cardiovascular diseases has high incidence and cannulas are widely used in cardiovascular procedures. Global Analysis Regionally, North America is anticipated to account for the largest share in the global cannula market till 2030 due to increasing prevalence of chronic diseases, growing elderly population, presence of major players, and developments in healthcare infrastructure. Asia Pacific is anticipated to grow at the fastest rate during the forecast period owing to growing medical tourism, rising healthcare expenditure, increasing incidence of chronic diseases, and growing medical device industry. China, India, and Japan are anticipated to drive the growth of the Asia Pacific cannula market during the forecast period.
